About Us

Committed to speeding innovation for science-driven organizations, from product ideation through commercialization.

Contur Software AB acquires iNovacia's research informatics division

iNovacia AB and Contur Software AB today announced that iNovacia's informatics division will be transferred to Contur.

The key assets are knowhow and software relating to R&D data management, laboratory automation, and discovery research workflow. The team members have on average 15 years professional experience from pharmaceutical and biotech informatics environments. The acquisition is effective of April 1 2010.

"We are focusing on our core business, drug discovery contract research, and strongly believe that the Informatics business will develop strongly in the solid environment for software design at Contur" said Thomas Olin, CEO of iNovacia. The continued collaboration between iNovacia and Contur to validate new research informatic's software will keep iNovacia at the absolute forefront of IP compliant and effective capturing of research data, Thomas Olin continues."

"This is a very positive move. We see a great opportunity in this affair. The iNovacia informatics platform and know-how is excellent and fits perfectly with Contur's ambitions to expand in the Life Science area" comments Martin Wattin, CEO of Contur.

"Combining this experience with Contur's expertise in the Electronic Laboratory Notebook field will strengthen our business and allow us to provide a broader range of tools for R&D labs" concludes Martin Wattin.

About iNovacia:
iNovacia provides drug discovery services to translate targets into validated leads for pharmaceutical and biotech companies as well as for universities and non-profit organizations. Enabled by a chemical library of highest international standard, unique biophysical tools for characterization of mode-of-action and SAR, iNovacia can minimize the technical risk and optimize lead-time and quality of drug discovery projects. Beyond a long-standing experience in drug discovery and development, specific strengths include assay development, "high-throughput screening", fragment-based screening, protein characterization, analytical chemistry, medicinal chemistry and in vitro ADME. For more information see www.inovacia.se.

Download the press release here.

Browse About Us

Contact Us

Corporate Headquarters

5005 Wateridge Vista Drive,
San Diego,
Tel: +1 858 799 5000

Browse By: